October is #BreastCancerAwareness Month. Are you aware that Nova Cells pioneered a highly successful cancer treatment approach that has put 50% of those treated with advanced cancer into full remission, and the rest in partial remission and oncostasis (No cancer progression)? Read more at http://www.novacellsinstitute.com/articles/DONOR-GRANULOCYTE-BASED-TMT-SAVING-END-STAGE-CANCER-PATIENTS-April-29-2014.pdf
Learn more about each of the disorders below by either following the link, or emailing or placing a call. Nova Cells has successfully treated many other conditions so if you do not see your particular challenge here, just ask us about our experience with it!
ALS (Lou Gehrig’s disease) – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410
Autism – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410
Cancer Cancer (End-stage & advanced too): http://www.novacellsinstitute.com/cancer-stem-cell-therapy.html
Cerebral Palsy – https://ncimx.wordpress.com/?s=Cerebral+Palsy
Chronic Fatigue Syndrome (CFS) – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410
Dementia/Lewy Body Dementia – https://ncimx.wordpress.com/?s=Dementia
Epilepsy/Other Seizure Disorders – https://ncimx.wordpress.com/?s=Seizure
Fibromyalgia – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410
Fibrosis – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410
Multiple sclerosis – https://ncimx.wordpress.com/?s=multiple+sclerosis
Parkinson’s Disease – See alzheimer’s-dementia
Spina Bifida – https://ncimx.wordpress.com/?s=Spina+Bifida
Spinal Cord Injury/Paralysis – https://ncimx.wordpress.com/?s=spinal+cord+injury
Traumatic Brain Injury – Email NCInfodesk@gmail.com for specifics or call 1-562-916-3410 begin_of_the_skype_highlighting
August 1 is #WorldLungCancerDay. This insidious form of cancer is one Nova Cells has had considerable success in treating. You can read more about the NCIM cancer program at http://www.novacellsinstitute.com/cancer-stem-cell-therapy.html
If you’d like specifics on advanced and end-stage cancer turnarounds* you should contact Grace Odgers, Ph.D. cand. using the information below:
Want to know more about NCIM and its pioneering immunologic treatment program for cancer? Call NCIM’s US information line at 1-562-916-3410 or email NCIM patient care facilitator/educator Grace Odgers, Ph.D. cand., by e-mail at firstname.lastname@example.org.
* Many, many cancer case histories have yet to be written up. Grace has specifics and will gladly share this with anyone who calls or emails her.
On Sunday December 7 (2014) CBS’s famed 60 Minutes devoted a thirteen minute segment titled “Disrupting Cancer” to physician and billionaire businessman Patrick Soon-Shiong, MD‘s advocacy and use of the rapid gene sequencing of tumor cells to help zero in specific drugs or other agents that will eradicate them. Later the same day, Forbes’s writer Matthew Herper published an article in which he stated something virtually everyone doing cancer work knows, namely that “Everyone is looking to use DNA sequencing to better pick cancer drugs. And in some ways, Soon-Shiong is an odd person to pick as a spokesperson for this, because he’s just getting started. ” (Here Is What ’60 Minutes’ Didn’t Tell You About The Billionaire Who Is Trying To Disrupt Cancer Care).
This is not to say that with Dr. Soon-Shiong’s deep pockets and army of computer experts and researchers he will not wind up making major inroads in this area of biomedicine. And with cancer striking so many, progress is welcome whether it comes out of a one person lab or a research enterprise that fills buildings or is stretched across many continents.
Nova Cells is no stranger to finding ways to “disrupt cancer”. It has, in fact, focused on a treatment approach that combines attacking tumors using donor immune cells (from healthy young people) and specific compounds that gum up the inner machinery in cancer cells while leaving healthy cells. It has been a spectacularly successful quest that started with the treatment of a 71 year old gentleman from the Pacific Northwest who was in the last throes of end-stage prostate cancer that had spread into his liver and bones. He was, in fact, so bad off that NCIM doctors thought he might not live more than a handful of days, at best. But, like so many people struggling with cancer, he was a spirited fighter who simply would not entertain abandoning hope until, as he put it, “I take my last breathe”.
This determined chap knew the score going into treatment, namely that he was volunteering to undergo something very experimental in nature. But he was resolutely committed to “fighting the good fight”, even if this pitched battle proved his last. Seeing his determined spirit, the MDs set about stabilizing him to help insure he could handle the biological blitzkrieg (lightening war) that NCIM’s experimental tumor-killing method was expected to unleash in his body.
Three days later the doctors began daily treatments using cancer-fighting cells (called granulocytes) that had been previously isolated from the blood of many young, healthy volunteers and then combined and infused by intravenous (IV) means. In addition, he was to be given intentionally HLA mismatched umbilical cord stem cells.
If the treatment worked as anticipated, the donor granulocytes would attack the tumors and also send a “wake up call” to the immune system, i.e., alert the fellow’s own immune cells that something alien was present which they would then attack (One problem in cancer is that tumors send out biochemical signals that suppress the sufferer’s own innate tumor-fighting cells). In addition, the HLA mismatched umbilical cord blood stem cells would be attracted by growth factors secreted by the tumors, attach to them, and then be attacked by the patient’s own immune cells which would react to them as a foreign presence.
The outcome? He did had a mild immune reaction (rash) that was easily suppressed using an IV antihistamine. This is how NCIM’s own patient care coordinator, Grace Pena, Ph.D. cand., summed up what transpired:
“Within three days his face was pinkish and his hands were getting pink. He was eating so well that the staff could not believe it. After the 7th primed donor granulocyte treatment he was walking 1/2 mile around the hospital, and feeling great. He was feeling so good in fact that he decided to return to his home state of Washington to finish up a million dollar real estate deal. NCIM doctors and staff protested wanting him to finish the entire course of therapy but he was adamant about getting home, but promised to return and complete his care once his real estate deal was completed. This he did. By October his US oncologist reported that his PSA is 1.1, his prostate is smaller than a normal 20 year olds, and he could find no cancer at all. Also, his Alkaline Phosphatase level which was about 2,000 during his treatment had dropped to something around 89.”
This fellow remains in full remission to this day.
Following this exciting clinical success, other end-stage cancer patients were treated (prostate, breast, lung, others) using the same method. Fifty percent (50%) experienced tumor shrinkage (partial remission) while the rest (50%) went into full remission.
In addition, other cancer-fighting measures were tested both alone and in combination with the donor granulocytes & cord blood stem cells (Gr-UCSC). Those that resulted in tumor shrinkage or obliteration when used alone, as well as those that bolstered the anti-cancer impact of the Gr-UCSCs were retained.
Among these were two chemical compounds that throw a monkey wrench into the tiny power-generating factories (mitochondria) in tumor cells but do not adversely affect normal cells. They are, in technical parlance Patrick Soon-Shiong, MD, selective for malignant cells.
NCIM also selectively utilizes a unique injectable protein that amplifies the cancer-fighting activity of a patient’s own macrophages.
Returning now to that 60 Minutes segment: Dr. Soon-Shiong beamed about tackling cancer at an immunological level. Nova Cells doctors and staff wish him well in this quest, but can’t help adding that in many ways we left the starting gate years ago and are “already there” (That is, have made demonstrable progress and enjoyed great success).
If you’d like to know more about NCIM’s cancer treatment method, just click these links:
You can also email or call NCIM:
Do you wonder what sets NCIM apart from other stem cell medicine operations? We have summarized the major differences in a simple chart which you can access by clicking the image below or by clicking or keying in http://bit.ly/18Sf87t
Thousands of people have visited this website as part of “shopping” for a stem cell treatment. Many have chosen to be treated by Nova Cell’s after tallying up what it offers. Here is what they have discovered:
- Nova Cells Institute of Mexico (NCIM) was founded by doctors, researchers and others who have spent years in the “stem cell industry”, some having been a part of it almost from its beginning.
- NCIM’s uses adult not embryonic or fetal stem cells, e.g., stem cells from certifiably disease-free stem cells isolated from umbilical cord blood, placental tissues, and Wharton’s Jelly. It also isolates and uses stem cells from patient’s own bone marrow.
- NCIM has developed unique, proprietary technology & lab methods that have made it possible to not only to get stem cells to target tissues, but to prime them to respond to chemical cues by becoming specific cell types that promote repair and healing. No other firm anywhere has this.
- Treatments are done in modern, secure medical facilities in Mexico (Tijuana).
- NCIM has developed a powerful treatment for advanced cancer, e.g., treating patients with pooled donor granulocytes, which has gotten many cancer sufferers into partial and complete remission. Its doctors and scientists possess a precise protocol for doing this treatment safely, which no other hospital or clinic anywhere has.
- NCIM’s stem cell-based treatment has proved especially beneficial in people with cerebral palsy, spina bifida, multiple sclerosis, spinal cord injuries and traumatic brain injuries.
- NCIM’s contracted medical facilities & labs all enjoy approval by the Mexican equivalent of the FDA.
- NCIM’s Director of Laboratory Services, Abel Pena, was trained by the head of stem cell research for a major R & D company in southern California.
- The cost of NCIM’s stem cell treatments are typically far less than other private stem cell treatment operations, not only in Mexico but elsewhere in the world.
Your next step? It’s simple, just click this link and then register: http://www.novacellsinstitute.com/register.html (There is no cost or obligation whatsoever)
You can also get more information or ask questions by calling NCIM’s U.S. information line at 1-562-916-3410 or emailing NCIM at NCInfodesk@gmail.com